Published in Cancer on April 06, 2015
Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients. Turk J Urol (2017) 0.75
Racial and Ethnic Variation in Health-Related Quality of Life Scores Prior to Prostate Cancer Treatment. Sex Med (2017) 0.75
Caution with Use of the Expanded Prostate Cancer Index Composite-50 Urinary Bother Scale: How Voiding Dysfunction Modifies Its Performance. J Urol (2017) 0.75
Models for longitudinal data: a generalized estimating equation approach. Biometrics (1988) 27.90
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care (2003) 19.69
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
SF-36 health survey update. Spine (Phila Pa 1976) (2000) 12.41
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol (2009) 10.43
Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med (2013) 7.95
Quality of life after radical prostatectomy or watchful waiting. N Engl J Med (2002) 6.83
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology (2000) 6.42
Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA (2010) 5.78
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol (2011) 5.28
The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol (2004) 5.09
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ (2009) 3.58
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol (2014) 2.96
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol (2005) 2.72
Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. J Urol (2014) 2.26
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol (2014) 1.70
Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49
Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial. J Clin Oncol (2010) 1.37
Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer (2006) 1.15
Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology (2006) 1.01
Multidisciplinary care and management selection in prostate cancer. Semin Radiat Oncol (2013) 0.99
The Center for Prostate Disease Research (CPDR): a multidisciplinary approach to translational research. Urol Oncol (2009) 0.95
Models of care and NCCN guideline adherence in very-low-risk prostate cancer. J Natl Compr Canc Netw (2013) 0.95
Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis (2007) 0.92
Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int (2011) 0.92
A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels. Psychooncology (2014) 0.89
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy. PLoS One (2014) 0.83
Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology (2003) 0.82
Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. BJU Int (2014) 0.81
Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose? Scand J Urol (2014) 0.78
Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies. JAMA Oncol (2016) 1.04
Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening. J Urol (2015) 0.96
National trends in the management of low and intermediate risk prostate cancer in the United States. J Urol (2014) 0.95
Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clin Cancer Res (2014) 0.84
Recent Trends in PSA Testing and Prostate Cancer Incidence: A Look at Context. JAMA Oncol (2016) 0.83
Effect of Screening Mammography on Cancer Incidence and Mortality. JAMA Intern Med (2015) 0.81
Screening men at increased risk for prostate cancer diagnosis: Model estimates of benefits and harms. Cancer Epidemiol Biomarkers Prev (2016) 0.78
Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base. J Urol (2016) 0.77
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev (2017) 0.77
Is prostate cancer different in black men? Answers from 3 natural history models. Cancer (2017) 0.75
Missteps in Current Estimates of Cancer Overdiagnosis. Acad Radiol (2016) 0.75